JPRN-UMIN000014170招募中未知
The clinical study to explore the effecs of anagliptin on responses of plasma glucose and lipid in new-onset type 2 diabetic patients - The clinical study to explore the effecs of anagliptin on responses of plasma glucose and lipid in new-onset type 2 diabetic patients
Diabetes And Lifestyle Center, Tomonaga Clinic0 个研究点目标入组 30 人开始时间: 2014年6月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who take other oral hypoglycemic agent 2.Patients who are past history of hypersensitivity to anagliptin 3.Patients who are severe ketosis or diabetic coma, precoma, type 1 diabetes 4.Patients who are severe infection or perioperative, severe injury 5.Pregnant or woman of child-bearing potential 6.Patients who are severe renal dysfunction or dialysis ESRD 7.Patients who are severe hepatic dysfunction 8.Patients who are judged as inappropriate for inclusion by phsicians
研究者
相似试验
尚未招募
2 期
Agnikarma in disc prolapse.CTRI/2022/11/047012Shalu mol S
已完成
不适用
Clinical study to investigate the effects of anti-CD20 monoclonal antibody (Rituximab) in patients with refractory pulmonary arterial hypertension associated with connective tissue diseasePulmonary arterial hypertension associated with connective tissue diseaseJPRN-UMIN000016320The University of Tokyo Hospital6
尚未招募
不适用
Clinical research study to evaluate the effect on gingival inflammation of a toothpaste containing vitamin D in patients with established dental plaque and gingivitis.GingivitisACTRN12621000885897The University of Queensland80
已完成
不适用
A clinical study for evaluating the effects of maltitol on improving liver functioJPRN-UMIN000027503Soiken Inc.60
进行中（未招募）
不适用
Klinische Studie zur Untersuchung der Wirkung von Weißdorn-Extrakt WS® 1442 auf die Lebensqualität von Patienten mit Herzinsuffizienz NYHA II, die ein moderates Ausdauertraining absolvierenEine monozentrische, offene klinische Prüfung der Phase IV im ParallelgruppendesignEUCTR2006-004523-11-DEDr. Willmar Schwabe GmbH & Co. KG